UBS Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,101,275
Closed -$22.2M 9878
2021
Q3
$22.2M Sell
1,101,275
-234,545
-18% -$4.73M 0.01% 1062
2021
Q2
$49.9M Sell
1,335,820
-42,803
-3% -$1.6M 0.02% 640
2021
Q1
$35.3M Sell
1,378,623
-821,864
-37% -$21M 0.01% 776
2020
Q4
$48.5M Buy
2,200,487
+1,112,278
+102% +$24.5M 0.02% 604
2020
Q3
$19.6M Sell
1,088,209
-262,068
-19% -$4.71M 0.01% 922
2020
Q2
$34.3M Sell
1,350,277
-806,912
-37% -$20.5M 0.01% 621
2020
Q1
$39.6M Sell
2,157,189
-33,077
-2% -$608K 0.02% 508
2019
Q4
$48.3M Sell
2,190,266
-244,273
-10% -$5.38M 0.02% 618
2019
Q3
$35M Sell
2,434,539
-33,260
-1% -$478K 0.01% 693
2019
Q2
$38.9M Buy
2,467,799
+48,678
+2% +$767K 0.02% 645
2019
Q1
$35.4M Buy
2,419,121
+1,679,033
+227% +$24.6M 0.01% 674
2018
Q4
$7.91M Buy
740,088
+234,497
+46% +$2.51M ﹤0.01% 1396
2018
Q3
$7.72M Sell
505,591
-101,408
-17% -$1.55M ﹤0.01% 1577
2018
Q2
$7.44M Buy
606,999
+5,177
+0.9% +$63.4K ﹤0.01% 1568
2018
Q1
$5.75M Sell
601,822
-10,305
-2% -$98.5K ﹤0.01% 1743
2017
Q4
$5.53M Sell
612,127
-2,890
-0.5% -$26.1K ﹤0.01% 1766
2017
Q3
$3.54M Buy
615,017
+331,084
+117% +$1.9M ﹤0.01% 2023
2017
Q2
$900K Sell
283,933
-712
-0.3% -$2.26K ﹤0.01% 2996
2017
Q1
$968K Buy
284,645
+1,599
+0.6% +$5.44K ﹤0.01% 2855
2016
Q4
$815K Buy
283,046
+17,271
+6% +$49.7K ﹤0.01% 2970
2016
Q3
$1.56M Buy
265,775
+259,400
+4,069% +$1.53M ﹤0.01% 2429
2016
Q2
$19K Buy
+6,375
New +$19K ﹤0.01% 5480
2016
Q1
Sell
-242
Closed -$3K 6967
2015
Q4
$3K Sell
242
-1,047
-81% -$13K ﹤0.01% 6506
2015
Q3
$11K Buy
1,289
+289
+29% +$2.47K ﹤0.01% 5877
2015
Q2
$14K Sell
1,000
-1,715
-63% -$24K ﹤0.01% 5771
2015
Q1
$65K Buy
+2,715
New +$65K ﹤0.01% 4471